Agenus Inc. [AGEN] shares are up more than 55.30% this year and recently decreased -0.1% or -$0.39 to settle at $4.10. AGEN has a short ratio of 8.28. This implies that the market is currently less bearish on the outlook for AGEN.

On 14, October 2020, Agenus to Present on Seven Novel Programs at SITC 2020. According to news published on Yahoo Finance, Clinical Responses: AGEN1181 (Fc-enhanced anti-CTLA-4) +/- balstilimab.

Analyst Birdseye View:

The most recent analyst activity for Agenus Inc. [NASDAQ:AGEN] stock was on April 22, 2019, when it was Initiated with a Buy rating from B. Riley FBR. Before that, on November 19, 2019, B. Riley FBR Recapitulated a Buy rating and elevated its amount target to $6. On October 28, 2016, H.C. Wainwright Downgrade a Neutral rating and plunged its price target on this stock from $10 to $5. On October 27, 2016, Maxim Group Reiterated a Buy rating. On March 11, 2016, Maxim Group Upgrade a Buy rating and increased its price target to $7. On December 16, 2015, Jefferies Initiated a Buy rating. On October 27, 2015, Maxim Group Downgrade a Hold rating. On July 27, 2015, MLV & Co Reiterated a Buy rating and improved its amount target to $11.

In the past 52 weeks of trading, this stock has oscillated between a low of $1.82 and a peak of $5.63. Right now, the middling Wall Street analyst 12-month amount mark is $8.00. At the most recent market close, shares of Agenus Inc. [NASDAQ:AGEN] were valued at $4.10.

FUNDAMENTAL ANALYSIS

Agenus Inc. [NASDAQ:AGEN] most recently reported quarterly sales of 79.89 billion, which represented growth of 71.30%. This publicly-traded organization’s revenue is $125,114 per employee, while its income is -$543,170 per employee. This company’s Gross Margin is currently 99.30%, its Pretax Margin is -440.53, and its Net Margin is -434.14.

It shows enduring liability to assets at 0.10 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 3.94 points at 1st support level, the second support level is making up to 3.77. But as of 1st resistance point, this stock is sitting at 4.41 and at 4.71 for 2nd resistance point.

Agenus Inc. [AGEN] reported its earnings at -$0.28 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.27/share signifying the difference of -0.01 and -3.70% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were -$0.31 calling estimates for -$0.33/share with the difference of 0.02 depicting the surprise of 6.10%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Agenus Inc. [NASDAQ:AGEN] is 0.70. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.78. Now if looking for a valuation of this stock’s amount to sales ratio it’s 7.17.

Insider Stories

The most recent insider trade was by INCYTE CORP, 10% Owner, and it was the sale of 0.14 million shares on Jun 17. INCYTE CORP, the 10% Owner, completed a sale of 72080.0 shares on Jun 16. On Jun 15, INCYTE CORP, 10% Owner, completed a sale of 0.38 million shares.